News
Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...
Astria Therapeutics ( NASDAQ: ATXS) is a Boston-based pre-commercial biotech developing two late-stage candidates (Navenibart and STAR-0310). The company was initially known as Catabasis ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
By now, the North Korean fake IT worker problem is so ubiquitous that if you think you don't have any phony resumes or imposters in your interview queue, you're asleep at the wheel.
South Carolina Republican State Senator and current candidate for governor Josh Kimbrell is being sued by his business ...
Anthropic shifted its stance on AI use in job applications, allowing job candidates to collaborate with its chatbot Claude in ...
AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that circulate in the blood, then build-up in the heart, kidney, liver, and other organs.
Infosys is recalibrating its recruitment strategy with a shift from virtual-only hiring to a hybrid model, driven by internal ...
Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a ...
Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune responses were ...
Shaun Maguire’s comment on Mamdani drew sharp backlash from global founders, with over 100 demanding an apology and action from Sequoia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results